Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
MedTech
FTC outlines antitrust case against Edwards' JenaValve deal
In its opening statement, the FTC said Edwards would control the only two potential TAVR systems designed to treat aortic regurgitation.
Conor Hale
Nov 25, 2025 3:10pm
FTC sues to block Surmodics acquisition over coating competition
Mar 7, 2025 11:00am
Thermo Fisher collects green lights for $3.1B Olink takeover
Jul 8, 2024 10:25am
Grail to become an Illumina spinout, once again, and go public
Jun 3, 2024 5:45pm
Illumina gets go-ahead from EU to part ways with Grail
Apr 12, 2024 10:11am
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am
